186 related articles for article (PubMed ID: 26738763)
1. Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).
Ribitzky-Eisner H; Minuhin Y; Greenberg D; Greenberg N; Chodick G; Craiu M; Leibovitz E
Pediatr Neonatol; 2016 Oct; 57(5):378-384. PubMed ID: 26738763
[TBL] [Abstract][Full Text] [Related]
2. The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization.
Leibovitz E; David N; Ribitzky-Eisner H; Abo Madegam M; Abuabed S; Chodick G; Maimon M; Fruchtman Y
Int J Environ Res Public Health; 2016 Jul; 13(7):. PubMed ID: 27447651
[TBL] [Abstract][Full Text] [Related]
3. Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.
Hernández-Bou S; Gómez B; Mintegi S; García-García JJ;
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1449-1455. PubMed ID: 29736610
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
Hum Vaccin Immunother; 2016; 12(2):268-76. PubMed ID: 26430921
[TBL] [Abstract][Full Text] [Related]
6. Occult Bacteremia: Should We Look for the Needle in the Haystack?
Baram N; Megged O; Weiser G
Isr Med Assoc J; 2016 Nov; 18(11):649-651. PubMed ID: 28466611
[TBL] [Abstract][Full Text] [Related]
7. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
Stoll ML; Rubin LG
Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
Benito-Fernández J; Mintegi S; Pocheville-Gurutzeta I; Sánchez Etxaniz J; Gómez Cortés B; Hernández Almaraz JL
Pediatr Infect Dis J; 2010 Dec; 29(12):1142-4. PubMed ID: 20592642
[TBL] [Abstract][Full Text] [Related]
9. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
[TBL] [Abstract][Full Text] [Related]
10. Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review.
Bressan S; Berlese P; Mion T; Masiero S; Cavallaro A; Da Dalt L
Acta Paediatr; 2012 Mar; 101(3):271-7. PubMed ID: 21950707
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital.
Zaitoon H; Bamberger E; Yaniv L; Mendelson B; Srugo I; Chistyakov I
Isr Med Assoc J; 2020 Feb; 22(2):71-74. PubMed ID: 32043321
[TBL] [Abstract][Full Text] [Related]
12. Bacteremia in Children 3 to 36 Months Old After Introduction of Conjugated Pneumococcal Vaccines.
Greenhow TL; Hung YY; Herz A
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28283611
[TBL] [Abstract][Full Text] [Related]
13. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
Shibl AM; Memish ZA; Al-Kattan KM
Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
[TBL] [Abstract][Full Text] [Related]
15. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Somekh E; Aviner S; Miron D; Dagan R
Vaccine; 2014 Jun; 32(27):3452-9. PubMed ID: 24690148
[TBL] [Abstract][Full Text] [Related]
16. Impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on acute mastoiditis in children in southern Israel: A 12-year retrospective comparative study (2005-2016).
Sapir A; Ziv O; Leibovitz E; Kordeluk S; Rinott E; El-Saied S; Greenberg D; Kaplan DM
Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110485. PubMed ID: 33168224
[TBL] [Abstract][Full Text] [Related]
17. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
Sard B; Bailey MC; Vinci R
Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
[TBL] [Abstract][Full Text] [Related]
18. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.
Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
Clin Infect Dis; 2014 Dec; 59(12):1724-32. PubMed ID: 25159581
[TBL] [Abstract][Full Text] [Related]
19. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
[TBL] [Abstract][Full Text] [Related]
20. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
